Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:45:57.166Z.
Calculation as of: 2026-10-06T16:45:57.166Z.
Quote observation: 2026-10-06T16:44:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c84a17f2c5c981e3cafbb97a54cdccede593a8f239875ee545639e7176ba2e68
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$89.81M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.24M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.48M
EV/EBIT Ratio
23.81x
TTM Avg
34.08x
3Y Avg
34.41x
5Y Avg
73.74x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $85.33M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 13.56x | 11.03x | 8.69x | 166.50x |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.06M | N/A | N/A | N/A | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.81M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.24M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $90.16M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.32M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.07M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.48M | 23.81x | 34.08x | 34.41x | 73.74x |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-05-12 | 4.71x |
| 2026-05-11 | 4.35x |
| 2026-05-08 | 4.19x |
| 2026-05-07 | 4.76x |
| 2026-05-06 | 3.06x |
| 2026-05-05 | 2.92x |
| 2026-05-04 | 2.97x |
| 2026-05-01 | 2.97x |
| 2026-04-30 | 2.93x |
| 2026-04-29 | 2.87x |
| 2026-04-28 | 2.91x |
| 2026-04-27 | 3.01x |
| 2026-04-24 | 3.01x |
| 2026-04-23 | 2.97x |
| 2026-04-22 | 3.07x |
| 2026-04-21 | 3.01x |
| 2026-04-20 | 3.01x |
| 2026-04-17 | 3.10x |
| 2026-04-16 | 3.09x |
| 2026-04-15 | 3.09x |
| 2026-04-14 | 3.06x |
| 2026-04-13 | 2.97x |
| 2026-04-10 | 2.88x |
| 2026-04-09 | 2.95x |
| 2026-04-08 | 3.01x |
| 2026-04-07 | 2.91x |
| 2026-04-06 | 2.96x |
| 2026-04-02 | 3.01x |
| 2026-04-01 | 3.07x |
| 2026-03-31 | 2.91x |
| 2026-03-30 | 2.77x |
| 2026-03-27 | 2.86x |
| 2026-03-26 | 2.91x |
| 2026-03-25 | 2.99x |
| 2026-03-24 | 3.01x |
| 2026-03-23 | 2.96x |
| 2026-03-20 | 2.98x |
| 2026-03-19 | 3.05x |
| 2026-03-18 | 3.01x |
| 2026-03-17 | 3.09x |
| 2026-03-16 | 5.05x |
| 2026-03-13 | 5.38x |
| 2026-03-12 | 5.59x |
| 2026-03-11 | 5.24x |
| 2026-03-10 | 5.27x |
| 2026-03-09 | 5.47x |
| 2026-03-06 | 4.69x |
| 2026-03-05 | 4.60x |
| 2026-03-04 | 4.80x |
| 2026-03-03 | 4.82x |
| 2026-03-02 | 4.56x |
| 2026-02-27 | 4.82x |
| 2026-02-26 | 4.74x |
| 2026-02-25 | 4.63x |
| 2026-02-24 | 4.19x |
| 2026-02-23 | 4.19x |
| 2026-02-20 | 4.18x |
| 2026-02-19 | 4.21x |
| 2026-02-18 | 4.31x |
| 2026-02-17 | 4.34x |
| 2026-02-13 | 4.32x |
| 2026-02-12 | 4.32x |
| 2026-02-11 | 4.39x |
| 2026-02-10 | 4.51x |
| 2026-02-09 | 4.59x |
| 2026-02-06 | 4.54x |
| 2026-02-05 | 4.35x |
| 2026-02-04 | 4.53x |
| 2026-02-03 | 4.62x |
| 2026-02-02 | 4.62x |
| 2026-01-30 | 4.71x |
| 2026-01-29 | 4.87x |
| 2026-01-28 | 4.86x |
| 2026-01-27 | 4.89x |
| 2026-01-26 | 4.75x |
| 2026-01-23 | 4.72x |
| 2026-01-22 | 4.60x |
| 2026-01-21 | 4.40x |
| 2026-01-20 | 4.25x |
| 2026-01-16 | 4.36x |
| 2026-01-15 | 4.41x |
| 2026-01-14 | 4.33x |
| 2026-01-13 | 4.28x |
| 2026-01-12 | 5.06x |
| 2026-01-09 | 9.09x |
| 2026-01-08 | 11.04x |
| 2026-01-07 | 9.74x |
| 2026-01-06 | 9.55x |
| 2026-01-05 | 10.74x |
| 2026-01-02 | 11.21x |
| 2025-12-31 | 11.37x |
| 2025-12-30 | 11.26x |
| 2025-12-29 | 11.32x |
| 2025-12-26 | 10.95x |
| 2025-12-24 | 11.11x |
| 2025-12-23 | 11.07x |
| 2025-12-22 | 11.25x |
| 2025-12-19 | 10.90x |
| 2025-12-18 | 10.93x |
| 2025-12-17 | 10.90x |
| 2025-12-16 | 11.11x |
| 2025-12-15 | 11.30x |
| 2025-12-12 | 11.33x |
| 2025-12-11 | 11.23x |
| 2025-12-10 | 10.72x |
| 2025-12-09 | 10.13x |
| 2025-12-08 | 9.82x |
| 2025-12-05 | 9.43x |
| 2025-12-04 | 9.36x |
| 2025-12-03 | 8.51x |
| 2025-12-02 | 8.34x |
| 2025-12-01 | 9.02x |
| 2025-11-28 | 9.83x |
| 2025-11-26 | 9.70x |
| 2025-11-25 | 9.55x |
| 2025-11-24 | 9.27x |
| 2025-11-21 | 9.09x |
| 2025-11-20 | 8.85x |
| 2025-11-19 | 9.12x |
| 2025-11-18 | 8.98x |
| 2025-11-17 | 8.79x |
| 2025-11-14 | 9.13x |
| 2025-11-13 | 8.94x |
| 2025-11-12 | 19.19x |
| 2025-11-11 | 19.33x |
| 2025-11-10 | 18.93x |
| 2025-11-07 | 18.18x |
| 2025-11-06 | 18.19x |
| 2025-11-05 | 16.56x |
| 2025-11-04 | 18.91x |
| 2025-11-03 | 21.30x |
| 2025-10-31 | 22.83x |
| 2025-10-30 | 21.61x |
| 2025-10-29 | 21.63x |
| 2025-10-28 | 23.39x |
| 2025-10-27 | 23.97x |
| 2025-10-24 | 22.28x |
| 2025-10-23 | 21.72x |
| 2025-10-22 | 22.50x |
| 2025-10-21 | 24.27x |
| 2025-10-20 | 24.66x |
| 2025-10-17 | 22.77x |
| 2025-10-16 | 23.45x |
| 2025-10-15 | 23.49x |
| 2025-10-14 | 22.47x |
| 2025-10-13 | 23.13x |
| 2025-10-10 | 22.04x |
| 2025-10-09 | 24.72x |
| 2025-10-08 | 24.37x |
| 2025-10-07 | 24.03x |
| 2025-10-06 | 21.50x |
| 2025-10-03 | 22.16x |
| 2025-10-02 | 22.27x |
| 2025-10-01 | 22.22x |
| 2025-09-30 | 22.04x |
| 2025-09-29 | 21.24x |
| 2025-09-26 | 21.14x |
| 2025-09-25 | 21.27x |
| 2025-09-24 | 21.93x |
| 2025-09-23 | 19.96x |
| 2025-09-22 | 18.93x |
| 2025-09-19 | 18.55x |
| 2025-09-18 | 18.58x |
| 2025-09-17 | 17.84x |
| 2025-09-16 | 17.72x |
| 2025-09-15 | 18.38x |
| 2025-09-12 | 18.65x |
| 2025-09-11 | 18.72x |
| 2025-09-10 | 18.13x |
| 2025-09-09 | 18.39x |
| 2025-09-08 | 18.75x |
| 2025-09-05 | 19.86x |
| 2025-09-04 | 19.70x |
| 2025-09-03 | 19.44x |
| 2025-09-02 | 18.99x |
| 2025-08-29 | 18.55x |
| 2025-08-28 | 19.02x |
| 2025-08-27 | 19.01x |
| 2025-08-26 | 19.45x |
| 2025-08-25 | 18.84x |
| 2025-08-22 | 18.99x |
| 2025-08-21 | 17.69x |
| 2025-08-20 | 18.10x |
| 2025-08-19 | 17.67x |
| 2025-08-18 | 17.67x |
| 2025-08-15 | 18.91x |
| 2025-08-14 | 18.04x |
| 2025-08-13 | 18.67x |
| 2025-08-12 | 17.77x |
